CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Invert›
Products & Services›
Enablement
Enablement

Invert› offers Enablement

ProductOperating Status: Currently Offered

Enablement provides live bioprocess monitoring, run exploration, summaries, and reporting tools.

Loading
Overview

Enablement helps teams monitor live process runs against historical baselines and review data as it arrives. The product includes alerts, run summaries, a searchable run directory, process-flow views, yield calculations, and interactive reports.

It supports development and manufacturing workflows by bringing run context, process data, and analysis together for scientists and operations teams.

Enablement - Classification

Industry
  • Biotech Software
Tags
  • Software

More from Invert

  • Integrations logo

    Integrations

  • Models logo

    Models

  • Intelligence logo

    Intelligence

  • Foundation logo

    Foundation

Enablement - Direct Competitors

  • Eppendorf

    Eppendorf logo

    BioNsight cloud

    eppendorf.com

  • Culture Biosciences

    Culture Biosciences logo

    Console

    culturebiosciences.com

  • Securecell

    Securecell logo

    Lucullus

    securecell.ch

AttributeEnablementBioNsight cloudConsoleLucullus
ProviderInvertinvertbio.com500k raised · SeedEppendorfeppendorf.comCulture Biosciencesculturebiosciences.com101.6M raised · Series CSecurecellsecurecell.ch
Founded2021—2016—
Sells ToEnterprise, Pharma and biotech labs—Enterprise—
Pricing ModelRecurring, Software—Recurring—
Ownership——Venture Capital—
Enablement

Provider Invertinvertbio.com500k raised · Seed

Founded 2021

Sells To Enterprise, Pharma and biotech labs

Pricing Model Recurring, Software

Ownership —

BioNsight cloud

Provider Eppendorfeppendorf.com

Founded —

Sells To —

Pricing Model —

Ownership —

Console

Provider Culture Biosciencesculturebiosciences.com101.6M raised · Series C

Founded 2016

Sells To Enterprise

Pricing Model Recurring

Ownership Venture Capital

Lucullus

Provider Securecellsecurecell.ch

Founded —

Sells To —

Pricing Model —

Ownership —

Enablement - Similar Products & Services

  • Biobrain Supervise logo

    Biobrain Supervise

    sartorius.com